For early-stage technology and life sciences companies based in New Jersey, the Technology Business Tax Certificate Transfer Program, commonly known as the NOL Program, represents one of the most valuable non-dilutive funding sources available in the State. Administered by the New Jersey Economic Development Authority (NJEDA) in coordination with the New Jersey Division of Taxation, the program allows qualifying companies to sell their unused New Jersey Net Operating Loss (NOL) carryovers and unused Research and Development (R&D) tax credits to profitable New Jersey corporate taxpayers in exchange for cash. The result, for a successful applicant, is the conversion of an otherwise unusable tax asset into immediate working capital that can fund operations, research, hiring, and capital expenditures.
Program Summary
- Sale of tax benefits: Approved companies may sell unused NJ NOLs and unused R&D tax credits for at least 80% of their tax value to unrelated, profitable NJ corporate taxpayers.
- Annual program cap: Up to $75 million available statewide each program year, with $15 million set aside for businesses located in designated Innovation Zones, Opportunity Zones, or for certified minority or woman-owned businesses.
- Lifetime cap per business: $20 million in cumulative benefit per applicant company.
- Permitted uses of proceeds: Salaries, research and development, working capital, fixed assets, real estate, and other allowable operating expenditures.
Key Eligibility Requirements
- Industry: Applicant must be a qualifying Technology or Biotechnology business whose primary activity is the provision of a scientific process, product, or service, and must own Protected Proprietary Intellectual Property (PPIP) such as an issued patent, a registered copyright, or an exclusive license.
- New Jersey presence: The company must be headquartered or have a base of operations in New Jersey.
- Size: Fewer than 225 U.S. employees (including parent and all subsidiaries) at the time of application.
- Minimum NJ headcount: Full-time employees (FTE) physically working in New Jersey at least 80% of the time with a minimum of 1 NJ FTE if the company is less than three years from incorporation, 5 NJ FTEs if more than three but less than five years, and 10 NJ FTEs if more than five years.
- No net income: The applicant cannot have positive net operating income on either of its two most recent full-year GAAP income statements.
- Financial statements: GAAP financial statements (with footnotes) for the two most recent full years, compiled, reviewed, or audited by an independent CPA firm, for both the applicant and any parent company.
- NJ tax compliance: The applicant’s NJ Corporate Business Tax (CBT) returns, with all required schedules and attachments, must be filed with the NJ Division of Taxation by the June 30 program deadline. Filing a CBT extension does not extend the NOL application deadline.
- Cannabis restriction: Applicants holding (or controlled by holders of) a license or certification from the NJ Cannabis Regulatory Commission are ineligible to participate.
Important Deadlines (2026 Program Year)
- Application opens: May 1, 2026
- Application deadline: June 30, 2026 at 11:59 p.m. Eastern Time (no exceptions!)
- NJ CBT return filing deadline: Same as the application deadline – June 30, 2026
- Five-year NJ retention period: Beginning on the benefit closing date, sellers must maintain a headquarters or base of operations in New Jersey for five years or face a recapture of the face value of the certificate sold.
Fees
A non-refundable $1,000 application fee is required at submission. An approval fee equal to 1% of the final award amount applies to awards greater than $100,000, capped at a maximum total fee of $20,000. The $1,000 application fee is credited against the approval fee.
Final Thoughts
The NOL Program is best understood as a one-time monetization decision for each year’s eligible NOL & R&D tax assets. Companies that participate permanently surrender the ability to use those particular NOLs and credits, so the decision should be modeled accordingly. For pre-revenue or pre-net income NJ life science or tech companies that are years away from utilizing their tax assets directly, the program frequently delivers cash benefits that meaningfully extend runway and accelerate development.
Please contact your WG advisor to discuss whether the program is a fit for your company.
